Lipoprotein(a) apheresis in severe coronary heart disease: An immunoadsorption method

Artificial Organs

Volumn 22, Issue 2, 1998, Pages 135-139

  Ullrich, Heidrun ^a   Lackner, Karl J ^a   Schmitz, Gerd ^a,b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Apheresis; Atherosclerosis; Immunoadsorption; Lipoprotein(a); Low density lipoprotein

Indexed keywords

CARDIOLOGY; COVALENT BONDS; DRUG THERAPY; HEART; LIPOPROTEINS; SULFUR COMPOUNDS;

APHERESIS; CARDIOVASCULAR RISK; CORONARY ANGIOGRAPHY; CORONARY HEART DISEASE; DISULPHIDE BRIDGE; IMMUNOADSORPTION; LIPOPROTEIN(A); LOW DENSITY LIPOPROTEINS; MYOCARDIAL INFARCTION; RISK FACTORS;

DISEASES;

ALBUMIN; CHOLESTEROL; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; LIPID; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; APHERESIS; ARTICLE; ATHEROSCLEROSIS; CASE REPORT; CONTROLLED STUDY; FLUSHING; HEART INFARCTION; HUMAN; IMMUNOADSORPTION; ISCHEMIC HEART DISEASE; MALE; PRIORITY JOURNAL; RISK FACTOR; TACHYCARDIA;

EID: 0031936754     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1594.1998.05080.x     Document Type: Article

References (31)

1. Adult treatment Panel II. Circulation 1994;89:1329-445.
2. Scandinavian Simvastatin Survival Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-9.
3. Brown G, Albers JJ, Fisher LD, Schaefer SM, Lin JT, Kaplan C, Zhao ZQ, Bisson BD, Fitzpatrick VF, Dodge HAT. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 1990;323:1289-98.
4. Ornish D, Brown SE, Scherwitz LW, Billings JK, Armstrong WT, Ports TA, McLanahan SM, Kirkeide RL, Brand RJ, Gould KL. Can lifestyle changes reverse coronary heart disease? Lancet 1990;336:129-33.
5. Stoffel W, Borberg H, Greve V. Application of specific extracorporeal removal of low density lipoprotein in familial hypercholesterolemia. Lancet 1981;2:1005-7.
6. A new serum type system in man - the Lp system. Acta Path Microbiol Scand 1963;59:369-82.
7. McLean JW, Tomlinson JE, Kuang W-J, Eaton DJ, Chen EY, Fless GM, Scanu AM, Lawn RM. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 1987;330:132-7.
8. Fless GM, Rolih CA, Scanu AM. Isolation of apoprotein(a) from lipoprotein(a). J Lipid Res 1985;26:1314-23.
9. Utermann G, Menzel HJ, Kraft HG, Duha HC, Kemmler HG, Seitz C. Lp(a) glycoprotein phenotypes: Inheritance and relation of Lp(a) lipoprotein concentration in plasma. J Clin Invest 1987;80:458-65.
10. Utermann G. The mysteries of lipoprotein(a). Science 1989; 246:904-10.
11. Grainger DJ, Kirschenlohr HL, Metcalfe JC, Weissberg PL, et al. Proliferation of human smooth muscle cells promoted by lipoprotein(a). Science 1993;260:1655-8.
12. Grainger DJ, Kemp PR, Liu AC, et al. Activation of transforming growth factor-β is inhibited in transgenic apolipoprotein(a) mice. Nature 1994;370:460-2.
13. Seed M, Hoppichler F, Reaveley D, et al. Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. N Engl J Med 1990;322:1494-9.
14. Scanu A, Fless G. Lipoprotein(a) heterogeneity and biological relevance. J Clin Invest 1990;85:1709-15.
15. Sandkamp M, Funke H, Schulte H, Köhler E, Assmann G. Lipoprotein(a) is an independent risk factor for myocardial infarction at young age. Clin Chem 1990;36(1):20-3.
16. Armstrong VW, Cremer P, Eberle E, Manke A. Schulze F, Wieland H, Kreuzer H, Seidel D. The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Atherosclerosis 1986;62:249-57.
17. Alfthan G, Pekkanen J, Jauhiainen M, Pitkaniemi J, Karvonen M, Tuomilheto J, Salonen JT, Ehnholm C. Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis 1994;106:9-19.
18. Ridker PM, Hennekens CH, Stampfer MJ. A prospective study of Lipoprotein(a) and the risk of myocardial infarction. JAMA 1993;270, 18:2195-225.
19. Thompson GR, Maher VMG, Matthews S, Kitano Y, Neuwirth C, Shortt MB, Davies G, Rees A, Prescott RJ, de Feyter P, Henderson A. Familial hypercholesterolaemia regression study: A randomised trial of low density lipoprotein apheresis. Lancet 1995;345:811-6.
20. Gavish D, Breslow JL. Lipoprotein(a) reduction by N-acetlycysteine. Lancet 1991;337(8735):203-4.
21. Breslow JL, Azrolan N, Bostom A. N-acetlycysteine and lipoprotein(a) (letter). Lancet 1992;339(8785):126-7.
22. Kroon AA, Demacker PN, Stalenhoef AF. N-acetlycysteine and serum concentrations of lipoprotein(a). J Intern Med 1991;230(6):519-26.
23. Wiklund O, Fager G, Andersson A, Lundstam U, Masson P, Hultberg B. N-acetlycysteine treatment lowers plasma homocysteine but not serum lipoprotein(a) levels. Atherosclerosis 1996;119(1):99-106.
24. Thompson GR, Lowenthal R, Myant NB. Plasma exchange in the management of homozygous familial hypercholesterolemia. Lancet 1975;1:1208-11.
25. Borberg H, Gaczkowski A, Hombach V, Oette K, Stoffel W. Treatment of familial hypercholesterolemia by means of specific immnunoadsorption. J Clin Apheresis 1988;4:59-65.
26. Yokoyama S, Hayashi R, Satani M, Yamamoto A. Selective removal of low density lipoprotein by plasmapheresis in familial hypercholesterolemia. Atherosclerosis 1985;5:613.
27. Ritter MM, Sühler, Richter W, Schwandt P. Short and long-term effects of LDL-apheresis on lipoprotein(a) serum levels. Clin Chim Acta 1990;195:9-16.
28. Seidel D, The H.E.L.P. system: An efficient and safe method of plasma therapy in the treatment of severe hypercholesterolemia. Ther Umsch 1990;47:514-9.
29. Bambauer R, Hahmann H. Plasmapherese: Technik und vergleichende Betrachtung der verschiedenen Verfahren ins besondere im Hinblick auf die extrakorporale LDL-Elimination. Dialyse J 1990;32:28-36.
30. Olbricht CJ. Extrakorporale Elimination von LDL-Cholesterin durch Apherese. Dtsch Med Wochenschr 1991; 116:625-30.
31. Pokrovsky SN, Adamova IY, Afanasieva OY, Benevolenskaya GF. Immunosorbent for selective removal of Lipoprotein(a) from human plasma: In vitro study. Artif Organs 1991;15(2):136-46.